Sequential Management with Gonadotropin-Releasing Hormone Agonist and Dienogest of Endometriosis-Associated Uterine Myoma and Adenomyosis
This study investigated the efficacy of sequential treatment with a GnRH agonist followed by dienogest for endometriosis-associated uterine myoma and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This chapter evaluates the sequential therapeutic approach combining gonadotropin-releasing hormone agonists with dienogest for managing patients presenting with both endometriosis-associated uterine myomas and adenomyosis. The authors outline a protocol designed to shrink fibroid tissue and alleviate symptoms associated with adenomyotic lesions through hormonal suppression followed by maintenance therapy. The text emphasizes that this combined strategy offers an alternative to immediate surgical intervention, particularly for women wishing to preserve fertility or avoid hysterectomy. This paper is centrally about endometriosis and adenomyosis, specifically focusing on the medical management of co-occurring uterine myomas alongside these conditions.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
531 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (24)
- A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
- A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women via openalex
- A rare case of de novo gigantic ovarian abscess within an endometrioma via openalex
- Coexistence of endometriosis in women with symptomatic leiomyomas via openalex
- Dienogest: a new therapeutic agent for the treatment of endometriosis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Endometrioma complicated by tubo-ovarian abscess in a woman with bacterial vaginosis via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- New progestagens for contraceptive use via openalex
- W2154693051 via openalex
- W2162130706 via openalex
- W4233426577 via openalex
- W1658784312 via openalex
- W1964793478 via openalex
- W1972292493 via openalex
- W2013397751 via openalex
- W2023365171 via openalex
- W2041524060 via openalex
- W2045458073 via openalex
- W2073744849 via openalex
- W2101417341 via openalex
- W2129134761 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00